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Abstract
Abnormalities in the JAK2/STAT3 pathway are involved in the pathogenesis of colorectal cancer (CRC), including apoptosis. However,
the exact mechanism by which dysregulated JAK2/STAT3 signalling contributes to the apoptosis has not been clarified. To investigate
the role of both JAK2 and STAT3 in the mechanism underlying CRC apoptosis, we inhibited JAK2 with AG490 and depleted STAT3 with
a small interfering RNA. Our data showed that inhibition of JAK2/STAT3 signalling induced CRC cellular apoptosis via modulating the
Bcl-2 gene family, promoting the loss of mitochondrial transmembrane potential (m) and the increase of reactive oxygen species. In
addition, our results demonstrated that the translocation of cytochrome c (Cyt c), caspase activation and cleavage of poly (ADP-ribose)
polymerase (PARP) were present in apoptotic CRC cells after down-regulation of JAK2/STAT3 signalling. Moreover, inhibition of
JAK2/STAT3 signalling suppressed CRC xenograft tumour growth. We found that JAK2/STAT3 target genes were decreased; meanwhile
caspase cascade was activated in xenograft tumours. Our findings illustrated the biological significance of JAK2/STAT3 signalling in CRC
apoptosis, and provided novel evidence that inhibition of JAK2/STAT3 induced apoptosis via the mitochondrial apoptotic pathway.
Therefore, JAK2/STAT3 signalling may be a potential target for therapy of CRC.
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Introduction
Colorectal cancer (CRC) is a commonly diagnosed malignancy and
a major cause of cancer-related death worldwide [1–3]. Despite
growing understanding of oncogenesis and successful identifica-
tion of proto-oncogenes and tumour suppressor genes involved in
the tumourigenesis of CRC, the biological and molecular mecha-
nisms in CRC are poorly understood. Recently, accumulated evi-
dence has shown that abnormalities in the Janus kinase 2/ signal
transducer and activator of transcription3 (JAK2/STAT3) signalling
pathway are associated with the oncogenesis of several cancers.
For example, some studies showed that sustained activation of the
JAK2 is a causal event [4, 5]. Moreover, constitutive activation of
STAT3 correlates with cell proliferation in non-small cell lung can-
cer [6] and pancreatic cancer [7]. Conversely, several studies have
demonstrated the proof of principle that modulating JAK2/STAT3
signalling arrests the growth of primary human cancer cells [8]
and promotes anti-tumour immunity in experimental cancer models
[9]. Additionally, excellent progress has been made in exploiting
STAT3 as a drug target in several forms of cancer [10]. Recently,
some studies have also found that inhibition of JAK2,3/STAT3 sig-
nalling induces apoptosis in CRC cells [11, 12].
Deregulation of apoptosis is an important aspect of cancer
pathogenesis and has been widely recognized as a hallmark of
most types of cancer [13]. There are two key molecular signalling
pathways that lead to apoptotic cell death. The first is the
 mitochondrial-mediated pathway [14], which is activated from
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inside the cell by members of Bcl-2 family and downstream
 mitochondrial signals. The second is the death receptor-mediated
pathway [15], which is activated from outside the cell by proapop-
totic ligands binding to specialized cell surface death receptors.
Both apoptosis pathways converge at the level of activation of
effector caspases activation, a family of cysteine proteases that are
present in most cells as inactive zymogens, and become activated
following a death signal. Activated caspases cleave cellular sub-
strates and carry out numerous proteolytic events that mediate the
apoptotic cell death program [16, 17]. Our previous study indicated
that JAK2/STAT3 signalling is involved in CRC cell growth and sur-
vival through regulating expression of genes, such as Bcl-2 [11].
However, no essential studies on the exact molecular mechanisms
of the apoptosis induced by inhibition of JAK2/STAT3 in CRC are
available. Since Bcl-2 can inhibit cytochrome c (Cyt c) release and
prevent opening of the megachannel by acting on the mitochondria
[18], we speculated that the mitochondrial-mediated pathway may
be involved in JAK2/STAT3 signalling induced apoptosis.
In this study, we used a fluorescent probe JC-1 or DCF fluores-
cence to detected m or reactive oxygen species (ROS), respec-
tively. The changes in expression of several proteins that are
directly related to the mitochondrial-mediated pathway, such as
Cyt c, caspases and Poly (ADP-ribose) polymerase (PARP), were
also evaluated. In addition, we tested the hypothesis that
JAK2/STAT3 signalling pathway could serve as a therapeutic tar-
gets in CRC xenograft models. Our findings illustrate the biologi-
cal significance of JAK2/STAT3 signalling in CRC apoptosis, and
provide novel evidence that inhibition of JAK2/STAT3 induces
apoptosis via the mitochondrial apoptotic pathway.
Materials and methods
Cell culture, treatment with pharmacologic agents
and transient transfection of STAT3 siRNA
Two human CRC cell lines SW1116 and HT29 were cultured in RPMI 1640
medium (Gibco BRL, Grand Island, NY, USA) and McCoy’s 5A medium
(Gibco), respectively, both supplemented with 10% foetal bovine serum at
37C in a humidified atmosphere with 5% CO2 supplemented. AG490
(Sigma-Aldrich, St. Louis, MO, USA), a pharmacological JAK2 inhibitor,
was dissolved in ethanol at a final concentration of 100 M. An appropri-
ate amount of ethanol was used as the control. Commercial STAT3 siRNA
(100 nM) used to target CRC cells was transfected with the DharmaFECT 1
siRNA transfection reagent (Thermo Scientific Dharmacon Inc., Lafayette,
CO, USA). Cells transfected with non-specific siRNA (Thermo Scientific
Dharmacon Inc.) were used as negative controls (NC).
Western blots
Western blot analysis to determine the levels of various proteins was 
performed using standard techniques as described previously [4]. For
loading control, the membrane was probed with a monoclonal antibody for
-tubulin. Antibodies used in this study were purchased from Cell
Signaling Technology, Danvers, MA, USA.
Detection of apoptosis
Mid-stage and late-stage apoptosis was determined by flow cytometry
analysis, using annexin-V FITC/propidium iodide double staining assay in
accordance with the manufacturer’s protocol (Becton Dickinson
Biosciences, Bedford, MA, USA).
Detection of mitochondrial membrane potential
To clarify whether the observed apoptosis was related to the changes of
mitochondrial membrane permeability, we used the fluorescent probe JC-1
(Invitrogen, Carlsbad, CA, USA) to measure the m of CRC cells according
to the manufacturer’s directions. Cells cultured in six-well plates after treat-
ment with AG490 or transient transfection with siRNA for 48 hrs or 72 hrs,
respectively, were incubated with JC-1 staining solution (10 g/ml) at 
37C for 10 min. The fluorescence intensities of both mitochondrial JC-1
monomers (ex, 495 nm; em, 530 nm) and aggregates (ex, 545 nm; em,
590 nm) were detected using the LSM510 confocal fluorescent microscope
(ZEISS, Germany) and analysed with Image J software. The m of CRC
cells in each treatment group was calculated as the ratio of the intensity of
green (i.e. monomers) to that of red (i.e. aggregates) fluorescence [19].
Determination of intracellular ROS generation
To further evaluate changes in mitochondria, we assessed the intracellular
concentration of ROS by using the non-fluorescent probe 2,7-dichloro-
fluorescein diacetate (DCFH-DA). The CRC cells were incubated with
DCFH-DA at 37C for 20 min. in dark conditions after treatment with AG490
for 48 hrs or being transient transfection with STAT3 siRNA for 72 hrs.
Signals were recorded by using a fluorescence microscope (Olympus 
IMT-2, Japan). The intracellular ROS concentration was quantified by the
measurement of the fluorescence intensity with Image J software.
Cyt c translocation
As transmutation of mitochondrial membrane permeability can induce Cyt
c translocation, we monitored the shift in Cyt c from the mitochondria to
the cytosol using the Cell Mitochondria Isolation Kit (Beyotime Institute of
Biotechnology, China). Samples of cytosol and mitochondria were 
dissolved in lyses buffer and probed with an antibody against Cyt c (Cell
Signaling Technology).
In vivo experiments
The CRC xenograft models were used to test the hypothesis that
JAK2/STAT3 signalling could serve as therapeutic targets. SW1116 cells
(1.0	107) were injected subcutaneously into the dorsal right flank of 
4-week-old male BALB/c nude mice (Experimental Animal Centre of SIBS)
to establish the CRC xenograft model. After the tumour diameter reached
5 mm, mice were randomly allocated (6 mice/group) and were treated by
injection with AG490 intraperitoneally at 10 mg/kg (low dose group) or 
15 mg/kg (high dose group) for 10 days and by way of multipoint intratu-
moural injection (10 g/30 l per tumour) of siRNA complexed with trans-
fection reagent in vivo jetPEI (Poly-plus-transfection Inc., NY, USA) [20]
every other day for 11 days. Tumour volume (mm3) was estimated by the 
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formula: tumour volume (mm3) 
 shorter diameter2	longer diameter/2.
The tumour volumes data are presented as means  SD. In addition,
Western blotting was performed to examine JAK2/STAT3 signalling activa-
tion and the activation of the caspase cascade in xenograft tumour tissues.
All experimental procedures were approved by the Institutional Animal
Care and Use Committee.
Statistical analysis
Results are shown as means  SD. Variance (ANOVA) was used to deter-
mine statistical significance among all groups. P  0.05 was considered
statistically significant. All analyses were performed using SPSS for
Windows 11.0.1 software.
Results
Inhibition of JAK2/STAT3 signalling induces CRC
cell apoptosis through regulation of Bcl-2 family
genes
Western blot analysis showed a time-dependent decrease in 
the expression of JAK2 and pJAK2 after treatment with AG490
(Fig. 1A). Meanwhile, AG490 exposure also decreased pJAK1 
levels in both CRC cell lines (Fig. S1A). Nevertheless, no signifi-
cant changes in the JAK3 and pJAK3 levels were detected by
AG490 treatment (Fig. S1A). In addition, AG490 decreased the
pSTAT3 levels in a time-dependent manner in SW1116 and HT29
cells. However, no detectable changes in the STAT3 level were
seen in AG490-treated cells. Therefore, we used a siRNA to selec-
tively reduce the expression of STAT3. Western blot analysis
revealed that both STAT3 and pSTAT3 were depleted in CRC cells
(Fig. 1B). Moreover, siRNA-mediated suppression of STAT3 did
not affect the expression of STAT5 or pstat5 (Fig. S1B).
To explore the effects of JAK2/STAT3 signalling on CRC cell
apoptosis we performed flow cytometry analysis (Fig. 2A). Our
studies demonstrated that there was a 17.6-fold increase in apop-
totic SW1116 cells and a 33.5-fold increase in apoptotic HT29
cells after 48 hrs of treatment with 100 M AG490. STAT3 siRNA
treatment also induced similar effects at 72 hrs after transfection
when apoptosis of SW1116 and HT29 cells increased by 4.43-
and 7.14-fold, respectively, higher than that in the control cells
transfected for the same period with nonspecific siRNA. We fur-
ther distinguished apoptosis from necrosis in these cells by flow
cytometry [21]. The proportions of necrotic SW1116 and HT29
cells were 1.3% and 0.7% respectively, after transient transfec-
tion with control siRNA. Meanwhile, the proportions of necrotic
Fig. 1 AG490 and STAT3 siRNA down-regulation of JAK2/STAT3 signalling. (A) Western blot analysis revealed that AG490 induced a time-dependent
decrease in JAK2 and pJAK2 levels in CRC cells. In the same experiment, decreases in pJAK1, and pSTAT3 levels were also identified, although 
the decrease in STAT3 was not statistically significant. (B) At 72 hrs post-transfection, Western blot analysis showed that STAT3 siRNA induced down-
regulation of STAT3 and pSTAT3 in CRC cells. -tubulin was used for the loading control. Quantification of the target protein bands relative to -tubulin
is shown in the right panel.
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SW1116 and HT29 cells were 3.4% and 1.8% respectively, after
transient transfection with STAT3 siRNA. These results showed
that there were no significant differences in the levels of necrosis
in STAT3 siRNA-treated cells compared with the control in both
CRC cell lines (Fig. S3). Together, these data indicated that
JAK2/STAT3 signalling is involved in the apoptotic process of
CRC cells.
To ascertain the molecular mechanism involved in the above
process, we examined the expression levels of apoptosis
related proteins known to be downstream targets of the
JAK2/STAT3 pathway. AG49 induced down-regulation of Bcl-2
simultaneously with the up-regulation of Bax in a time-dependent
manner in both SW1116 and HT29 cells (Fig. 2B). In addition,
similar effects were detected by transfection with siRNA for 
72 hrs to deplete STAT3 (Fig. 2C). Therefore, inhibition of
JAK2/STAT3 signalling induces apoptosis by altering the
 balance of the protein levels of these pro- and anti-apoptotic
molecules in CRC cells.
Disruption of JAK2/STAT3 signalling promotes the
loss of mitochondrial transmembrane potential
(m) and increase of ROS
Since many apoptosis signals originating from the mitochondria
are regulated through the Bcl-2 family [22], we hypothesized that
the modulation of Bcl-2 and Bax would result in the changes of the
mitochondrial transmembrane permeability. To further character-
ize the molecular mechanisms of JAK2/STAT3 signalling mediated
apoptosis, we measured m with in situ JC-1 staining after
AG490 or STAT3 siRNA treatment. Control cells treated with the
equivalent ethanol volume and then stained with JC-1 emitted
mitochondrial orange-red fluorescence with a small degree of
green fluorescence indicating hyperpolarized mitochondria.
However, aggregation of JC-1 within normal mitochondria was
replaced by diffuse green monomer fluorescence after treatment
with AG490 (Fig. 3A). Additionally, the same phenomenon was
Fig. 2 Apoptosis induced by disruption of JAK2/STAT3 signalling is associated with modulation of Bcl-2 family members. (A) CRC cells were treated with
100 M AG490 for 48 hrs or STAT3 siRNA for 72 hrs, and cell apoptosis was detected by flow cytometric analysis. (B) Western blot analysis showed that
AG490 induced time-dependent alterations of Bcl-2 family protein. Bcl-2 was down-regulated, simultaneously associated with the up-regulation of Bax.
A similar pattern of changes was identified in HT29 cells. (C) STAT3 siRNA induced similar effects to that of AG490 treatment, with down-regulation of
Bcl-2 and up-regulation of Bax detected at 72 hrs after transfection of the cells. -tubulin was used for the loading control.
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detected after transfection with STAT3 siRNA (Fig. 3A). Therefore,
the data suggested the occurrence of depolarization of mitochon-
dria and reduction of m in both SW1116 and HT29 cell lines by
disruption of JAK2/STAT3 signalling.
On the other hand, ROS can be scavenged by the members of
the Bcl-2 family, and up-regulation of ROS also leads to a reduc-
tion of m [23]. Therefore, we further determined whether the
changes in the Bcl-2 family could induce the alteration in ROS and
whether the reduction of m was partly induced by the up-
 regulation of ROS. We found significant increases in the intracel-
lular concentration of ROS in both SW1116 cells and HT29 cells
after AG490 or STAT3 siRNA treatment (Fig. 3C). Thus, the results
demonstrated that the apoptosis induced by inhibition of
JAK2/STAT3 signalling may be associated with the mitochondrial
pathway.
Inhibition of JAK2/STAT3 signalling induces 
the translocation of mitochondrial Cyt c 
to the cytosol
The alteration of m causes mitochondria to become permeable
by opening the mitochondrial permeability transition pores, which
is a pathway for the release of the apoptogenic protein Cyt c from
mitochondria into the cytoplasm [24]. Therefore, we detected the
Cyt c release after disruption of JAK2/STAT3 signalling. Western
blot analysis showed a time-dependent increase in the expression
of Cyt c in cytosol after treatment with 100 M AG490 (Fig. 4A).
Cyt c was almost undetectable in cytosol before treatment with
AG490 in SW1116 cells and the overall pattern was similar in
HT29 cells. Meanwhile, AG490 exposure also decreased in Cyt c
Fig. 3 Attenuated JAK2/STAT3 signalling decrease m and promote generation of ROS in CRC cells. (A) An increase indicates a shift in the fluorescence
ratio correlating with an increase in mitochondrial depolarization. Representative photographs of JC-1 staining in different groups. (B) Quantitative analy-
sis of the shift of mitochondrial orange-red fluorescence to green fluorescence among the different groups. All values are denoted as means  S.E.M.
derived from three independent photographs shot for each group. Significant differences are indicated as P  0.05 compared to the control cells. (C) The
corresponding DCF-fluorescent image induced after down-regulation of JAK2/STAT3 signalling. (D) The increase in the DCF-fluorescence intensity induced
by AG490 and STAT3 siRNA. Values are means  S.D. of three determinations (P  0.05).
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levels in mitochondria of both CRC cell lines. Cyt c expression
altered sharply after 48 hrs of exposure to AG490 in both cytosol
and mitochondria, suggesting that JAK2 may play an important
role in regulation of Cyt c translocation. To further evaluate the role
of STAT3, we down-regulated its expression by siRNA. Our data
suggested that STAT3 participated in Cyt c translocation from
mitochondria to cytosol at 72 hrs post-transfection (Fig. 4B).
Inhibition of JAK2/STAT3 signalling induces the
caspases cascade and PARP cleavage
Since the translocation of Cyt c can activate the caspase cascade
[25], we further explored whether caspases were involved after
inhibition of JAK2/STAT3 signalling. As illustrated in Figure 5A,
pretreatment of CRC cells with AG490 decreased the expressions
of pro-caspase9 and pro-caspase3, meanwhile increased the
expression of cleaved-caspase9 and cleaved-caspase3. We also
found that the most significant alteration emerged at 72 hrs after
exposure to AG490. STAT3 siRNA induced similar effects. At 72 hrs
after  transfection with 100 nM of STAT3 siRNA, the expressions of
 pro-caspases3,9 of SW1116 and HT29 cells decreased and
cleaved-caspases3,9 increased when compared with the equiva-
lent transfection with nonspecific siRNA (Fig. 5B). However, the
active caspase-8 involved in the death receptor pathway was not
significantly increased, after transient transfection with STAT3
siRNA for 72 hrs in both CRC cell lines (Fig. S2). Our results
 suggested that the caspase cascade involved in the mitochondrial
pathway is activated after inhibition of JAK2/STAT3 signalling.
To further explore the effects of JAK/STAT signalling on the
caspase cascade, we detected PARP, a substrate for caspase-3,
which is known to be a key substrate associated with apoptosis at
the nuclear level [26]. As seen in our results, PARP was cleaved
after 24 hrs of AG490 treatment in both CRC cell lines. STAT3
siRNA displayed the same phenomenon compared with NC.
Moreover, cleaved-PARP was almost undetectable after transfec-
tion with nonspecific siRNA.
Inhibition of JAK2/STAT3 signalling suppresses
CRC xenograft tumour growth
To determine whether components of JAK2/STAT3 could serve as
therapeutic targets, we established a tumour model in nude mice
bearing SW1116 xenografts. After treatment with different con-
centrations of AG490, we found that the tumour volume of the
high dose group (15 mg/kg) was smaller than that of the low dose
group (10 mg/kg) without obviously toxicity (P  0.05).
Moreover, transient transfection of STAT3 siRNA also led to the
slower growth of SW1116 xenografts when compared with the
mock or NC animal group (Fig. 6A).
Furthermore, we examined the protein levels of JAK2, pJAK2,
STAT3 and pSTAT3 of CRC xenografts by Western blot. As shown
in Fig. 6B, the JAK2/STAT3 signalling target proteins were all
Fig. 4 Inhibition of JAK2/STAT3 signalling induced Cyt c translocation in CRC cells. (A) After down-regulation of JAK2 using AG490, Cyt c migrated from
mitochondria to cytoplasm. The expression of Cyt c altered sharply after 48 hrs of exposure to AG490 in both cytosol and mitochondria. (B) The same
phenomenon was also seen in CRC cells after transient transfection with STAT3 siRNA.
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decreased when compared with the mock group. Meanwhile, we
investigated the level of activation of the caspase cascade after
AG490 or STAT3 siRNA treatment. As shown in Figure 6B,
changes of the JAK2/STAT3 pathway dramatically induced activa-
tion of the caspase cascade inside the tumours compared with the
mock or NC group. Taken together, these data indicated that tar-
geting JAK2/STAT3 could exert anti-tumour effects in vivo on CRC
and may serve as a therapeutic target.
Discussion
Abnormalities of the JAK/STAT pathway are involved in the patho-
genesis of several cancers [6] including apoptosis. However, the
molecular mechanism by which disordered JAK2/STAT3 signalling
contributes to apoptosis has not been clarified. Therefore, under-
standing the mechanisms of apoptosis is crucial to comprehend-
ing the role of the JAK2/STAT3 pathway in cancer therapies. Our
previous work found that inhibition of JAK2/STAT3 signalling
induced CRC cells apoptosis. However, the exact mechanisms
involved are still incompletely understood. In our study, we used
AG490 to inhibit JAK2, pJAK2 and pSTAT3 (Fig. 1). Although
AG490 has been widely used for inhibiting JAK2, it has unspecific
inhibit effects. To further demonstrate the exactly apoptosis path-
way involved in the CRC cells after inhibition of STAT3, we used
STAT3 siRNA to knock down STAT3.
There are many areas of uncertainty related to mechanisms of
apoptosis, including by overexpressing pro-apoptotic proteins and
inducing the signalling cascade at various levels. Our previous
study also found that the expression of Bcl-2 proteins that are
known to be downstream targets of the STATs pathway is
decreased after suppression of JAK2/STAT3 signalling. Therefore,
in this study we detected the members of the Bcl-2 family, the anti-
apoptosis protein Bcl-2 and the pro-apoptosis protein Bax. The
down-regulation of Bcl-2 and up-regulation of Bax were observed
in a time-dependent manner in CRC cells after alteration of
JAK2/STAT3 signalling (Fig. 2).
Fig. 5 Disruption of JAK2/STAT3 signalling induces caspase-dependent apoptosis in CRC cells. (A) Pro-caspase9 and pro-caspase3 decreased, while
cleaved-caspase9 and cleaved-caspase3 increased after treatment with AG490 in a time-dependent manner. (B) A similar pattern of changes was identi-
fied after transfection with STAT3 siRNA. (C) PARP was cleaved in a time-dependent manner after AG490 treatment and pro-PARP was reduced simulta-
neously. (D) Effects of STAT3 siRNA on the cleavage of PARP. At 48 hrs post-transfection, pro-PARP expression was down-regulated and cleaved-PARP
up-regulated compared to that of negative control.
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The permeabilization of the mitochondrial outer membrane is
tightly controlled by Bcl-2 [21, 27], and activation of Bax can trig-
ger a sequence of events that leads to alterations in mitochondrial
permeability transition [28]. Therefore, we turned our attention to
and found that reduction of m emerged in both CRC cells after
inhibition of JAK2/STAT3 signalling as indicated by an increase in
the green/red ratio (Fig. 3A). The results indicated that the
changes of mitochondrial outer membrane permeabilization con-
stitute one of the major checkpoints of JAK2/STAT3 signalling
induced CRC cell apoptosis. Moreover, abnormal expression of
Bcl-2 family protein may be the trigger involved in JAK2/STAT3
signalling induced m down-regulation.
Besides, mitochondria are major sources of ROS, and the
reduction in the level of Bcl-2 would promote the generation of
ROS [29]. To explore whether ROS participates in JAK2/STAT3
signalling induced apoptosis, we detected the concentration of
ROS. An increase of ROS concentration was seen in CRC cells
after suppression of JAK2/STAT3 signalling. This result indicates
that JAK2/STAT3 induced apoptosis could stimulate oxidative
stress via generation of ROS, which provides a feed forward sig-
nal to reduce m and cell apoptosis.
Since m was shown to be down-regulated, we further
detected Cyt c translocation from the mitochondrial to the cyto-
plasmic compartment in a time-dependent efflux after inhibition
of JAK2/STAT3 signalling. Translocation of Cyt c is associated
with proteolytic processing of caspase-9 and subsequent activa-
tion of effector caspases [30]. On the other hand, caspase 9 is
dependent primarily on mitochondrial signalling pathways regu-
lated by members of the Bcl-2 family [31, 32]. Since caspases
play a central role in virtually all known apoptotic signalling path-
ways, it is not surprising that they have been implicated in
JAK2/STAT3 signalling induced apoptosis. In our study, we
Fig. 6 Suppression of established tumour growth in nude mice by AG490 and STAT3 siRNA. (A) AG490 and STAT3 siRNA suppressed SW1116 xenograft
tumour growth. Tumour volume was smaller compared with the negative group after treatments. Representative photographs of a mouse in each SW1116
xenograft group are shown. The tumour volumes measurements are means  S.D. (n 
 6). (B) JAK2/STAT3 signalling and caspase cascade in SW1116
xenografts mice analysed by Western blot.
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observed activation of the caspase9 after treatment with AG490
in a time-dependent manner and after transient transfection of
STAT3 siRNA. The activation of caspase-9 subsequently stimu-
lated downstream caspases-3, which were activated through the
mitochondrial signalling pathway. Caspase-3 cleaves several sub-
strates, such as PARP, resulting in chromosomal DNA fragmenta-
tion and cellular apoptosis, which were also showed in our study.
All of these results demonstrated that inhibition of JAK2/STAT3
signalling could down-regulated m via modulating the expres-
sion of Bcl-2 family genes and oxidative stress. Moreover, the
down-regulation of m causes Cyt c to be translocated from the
mitochondria to the cytoplasm to activate downstream caspase
cascade and PARP, which ultimately leads to apoptosis in CRC
cells (summarized in Fig. 7).
To test the hypothesis that JAK2/STAT3 signalling could serve 
as a therapeutic target, we constructed a nude mouse CRC cell
xenograft model. SW1116 cells are widely used in tumour xenograft
model [33, 34] and were injected subcutaneously into the dorsal
right flank of nude mice. AG490 and STAT3 siRNA were shown to
cause marked tumour regression without apparent toxicities in
these mice. These results could be explained by either the down-
regulation of target genes or by the activation of the caspase
 cascade after inhibition of the JAK2/STAT3 signalling. Our results
demonstrate that JAK2/STAT3 signalling could be a potential
 therapeutic target in CRC. Although tumour subcutaneous xenograft
model is useful for enhancing our understanding of cancer develop-
ment and treatment, there are several disadvantages and challenges
of using the mouse xenograft model to monitor and/or predict
 therapeutic responses in cancer. Therefore, primary human
tumours and further studies are needed to validate this hypothesis
Since mitochondrial pathway is not the only apoptosis pathway
involved in cancer cell death, we also detected whether death
receptor pathway participated in AG490 and STAT3 induced CRC
cells apoptosis. Death inducing signalling complex induced the
activation of caspase-8, which in turn precipitated the activation of
downstream effector caspases in the death receptors pathway.
Therefore, we detected the activation of caspase-8 by ELISA. Our
result showed that there were no significant differences after tran-
sient transfection of STAT3 siRNA in both CRC cell lines (Fig. S2).
Therefore, STAT3 siRNA induced CRC cells apoptosis mainly via
the mitochondrial pathway.
Both apoptosis and necrosis are two important mechanisms of
cell death. We further considered whether inhibition of
JAK2/STAT3 signalling could induce CRC cell necrosis. In order to
do so, it was necessary to quantify and distinguish between apop-
totic and necrotic cells using a flow cytometric method. Although
it seemed that there were more necrotic cells in the STAT3 siRNA
treatment group than the NC, the differences were not significant
in either CRC cell line (Fig. S3). Based on these results, STAT3
siRNA induced cell death mainly through apoptosis.
In conclusion, this study is the first to have examined in detail
the molecular mechanism of JAK2/STAT3 signalling in CRC apop-
tosis. Our present findings suggest that inhibition of JAK2/STAT3
signalling induces CRC apoptosis via the mitochondrial pathway.
Thus, our data provide further support for targeting the
JAK2/STAT3 signalling in the potential treatment of human CRC.
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Fig. 7 Model of the possible mechanism of JAK2/STAT3 signalling in the
apoptosis of CRC. Inhibition of JAK2/STAT3 induces CRC cell apoptosis,
while changing the expression of Bcl-2 and Bax which are involved in reg-
ulating the mitochondrial membrane permeability. Therefore, a decrease of
m accompanied by the generation of ROS is detected after down-regu-
lation of JAK2/STAT3 signalling. Moreover, because of the lowered m,
Cyt c is translocated from mitochondrial to cytoplasmic to activate the cas-
pase cascade. Furthermore, as shown by the data in this study, activated
caspase3 cleaves PARP finally resulting in chromosomal DNA fragmenta-
tion and CRC apoptosis.
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Fig. S1 Effect of AG490 and STAT3 siRNA on JAK/STAT pathway
genes. (A) Western blot analysis revealed that AG490 induced a
decrease in pJAK1 levels at 24 hrs in CRC cells. In the same exper-
iment, JAK1, JAK3 and pJAK3 also identified although these
decreases were not statistically significant. (B) At 72 hrs post-
transfection, Western blot analysis showed that STAT3 siRNA did
not affect the expressions of STAT5 and pSTAT5. The data shown
are representative of three separate experiments. -tubulin was
used for the loading control. Quantification of the target protein
bands relative to tubulin is shown in the right panel.
Fig. S2 Inhibition of STAT3-induced CRC cells apoptosis may not
be associated with the death receptor pathway. Activated caspase-
8 showed no significant difference between control siRNA group
and STAT3 siRNA group as detected by ELISA in both CRC cell
lines after transient transfection for 72 hrs.
Fig. S3 Suppression of STAT3 does not induce CRC cell necrosis.
CRC cells were treated with STAT3 siRNA for 72 hrs and cell apop-
tosis and necrosis were detected by flow cytometric analysis. The
lower left quadrant, the upper and lower right quadrant and the
upper left quadrant represent viable cells, apoptotic cells and
necrotic cells, respectively. Although the number of the necrotic
cells in the STAT3 siRNA treatment group seemed to be greater
than that of negative control, these differences were not significant
in either CRC cell line.
Please note: Wiley-Blackwell are not responsible for the content or
functionality of any supporting materials supplied by the authors.
Any queries (other than missing material) should be directed to
the corresponding author for the article.
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